Arthritis Drug
-
{
- All
- News
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
Two Arthritis Drugs Reduce Risk Of Covid Death, Shows Study
Arthritis drugs tocilizumab and sarilumab reduce the risk of death and the need for ventilators among hospitalized Covid-19 patients, according to an analysis of nearly 11,000 patients published Tuesday.
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
Arthritis Drug May Help Treat Rare Eye Disease: Study
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
-
Arthritis Drug May Help Treat Rare Eye Disease: Study
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
-
Government Rejects Patent on Pfizer's Arthritis Drug
Government has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
Skin lesions with arthritis drugs
Treatment of rheumatoid arthritis with the potent TNF-alpha blocking drugs is linked to an increase in dermatological conditions.
-
Newer arthritis drugs linked to skin disorder
New drugs for arthritis can lead to the development of an inflammatory disorder of blood vessels, usually affecting the skin.
-
Arthritis drug link to lymphoma unclear
Certain rheumatoid arthritis drugs have been linked to an increased risk of lymphoma, a type of lymph node cancer. However, recent research suggests that these drugs do not cause lymphoma but that they are simply more likely to be given to patients destined to develop the cancer.
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
Two Arthritis Drugs Reduce Risk Of Covid Death, Shows Study
Arthritis drugs tocilizumab and sarilumab reduce the risk of death and the need for ventilators among hospitalized Covid-19 patients, according to an analysis of nearly 11,000 patients published Tuesday.
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
Arthritis Drug May Help Treat Rare Eye Disease: Study
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
-
Arthritis Drug May Help Treat Rare Eye Disease: Study
A popular rheumatoid arthritis medication may effectively treat non-infectious uveitis, a rare eye disease that can lead to loss of vision, a new study has claimed.
-
Government Rejects Patent on Pfizer's Arthritis Drug
Government has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
Skin lesions with arthritis drugs
Treatment of rheumatoid arthritis with the potent TNF-alpha blocking drugs is linked to an increase in dermatological conditions.
-
Newer arthritis drugs linked to skin disorder
New drugs for arthritis can lead to the development of an inflammatory disorder of blood vessels, usually affecting the skin.
-
Arthritis drug link to lymphoma unclear
Certain rheumatoid arthritis drugs have been linked to an increased risk of lymphoma, a type of lymph node cancer. However, recent research suggests that these drugs do not cause lymphoma but that they are simply more likely to be given to patients destined to develop the cancer.
